Cardiovascular prevention: Relationships between arterial aging and chronic drug treatment

Journal of Human Hypertension

Volumn 25, Issue 9, 2011, Pages 524-531

  Lieber, A ^a   Millasseau, S ^b   Mahmud, A ^c   Bourhis, L ^a   Mairesse, S ^a   Protogerou, A ^a   Agnoletti, D ^a   Zhang, Y ^a   Blacher, J ^a   Safar, M E ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AtCor Medical   (France)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

arterial aging; cardiovascular prevention; drug treatment

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SPIRONOLACTONE;

ADULT; AGING; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CONTROLLED STUDY; DIABETES MELLITUS; DIURETIC THERAPY; FEMALE; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; PULSE PRESSURE; STATISTICAL ANALYSIS; TONOMETRY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PULSATILE FLOW;

EID: 80052030829     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.28     Document Type: Article

References (27)

1. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part I: Aging arteries: A 'set up' for vascular disease. Circulation 2003; 107: 139-146.
2. Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME. Blood pressure response under chronic antihypertensive drug therapy: The role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol 2009; 53: 445-451.
3. Safar ME, Blacher J, Protogerou A, Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J Hypertens 2008; 26: 130-137.
4. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
5. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith Jr SC et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries. Circulation 2007; 116: 1942-1951.
6. El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: The Omron M5-I and the Omron 705IT. Blood Press Monit 2003; 8: 127-133.
7. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993; 14: 160-167.
8. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608.
9. Chen CH, Ting CT, Lin SJ, Hsu TL, Yin FC, Siu CO et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995; 25: 1034-1041.
10. Topouchian J, Asmar R, Sayegh F, Rudnicki A, Benetos A, Bacri AM et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999; 30: 1056-1064.
11. Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. Does radial artery pressure accurately reflect aortic pressure? Chest 1992; 102: 1193-1198.
12. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA et al. Noninvasive assessment of local arterial pulse pressure: Comparison of applanation tonometry and echotracking. J Hypertens 2001; 19: 1037-1044.
13. Nichols WW, O'Rourke MF. McDonald's Blood Flow in arteries. Theoretical, Experimental and Clinical Principles, 4th edn, Edward Arnold: London, 2006, pp 49-94, 193-233, 339-402, 435-502.
14. Asmar R, Topouchian J, Pannier B, Benetos A, Safar M. Pulse wave velocity as endpoint in large-scale intervention trial. The complior study. Scientific, quality control, coordination and investigation committees of the complior study. J Hypertens 2001; 19: 813-818.
15. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
16. Smulyan H, Siddiqui DS, Carlson RJ, London GM, Safar ME. Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension 2003; 42: 150-155.
17. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD et al. Role of pulse pressure amplification in arterial hypertension: Experts' opinion and review of the data. Hypertension 2009; 54: 375-383.
18. Asmar RG, Benetos A, Chaouche-Teyara K, Raveau-Landon CM, Safar ME. Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension. Am J Cardiol 1993; 72: 794-798.
19. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90: 2786-2796.
20. Safar ME, Temmar M, Kakou A, Lacolley P, Thornton SN. Sodium intake and vascular stiffness in hypertension. Hypertension 2009; 54: 203-209.
21. London GM, Asmar RG, O'Rourke MF, Safar ME. and on behalf of the REASON project, Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol. J Am Coll Cardiol 2004; 43: 92-99.
22. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
23. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008; 21: 663-667.
24. Dhakam Z, Yasmin CM, McEniery T, Burton MJ, Brown, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008; 26: 351-356.
25. Van Bortel LM, Struijker-Boudier HA, Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38: 914-921.
26. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438.
27. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464-1470.